Skip to main content

First AI medical diagnostic device approved by FDA

by Futures Centre, May 16
1 minute read

The United States Food and Drug Administration has permitted the marketing of the first ever medical device that uses artificial intelligence to detect mild levels of diabetic retinopathy, an eye disease found in adults who suffer from diabetes. The device can be used by a primary care doctor, as opposed to an eye specialist, to determine whether the patient has “more than mild” or “negative for more than mild” diabetic retinopathy. If the device determines that they have more than mild symptoms, the patient is then recommended to a specialist for further evaluation and to begin treatment.

back of eye

Details

by Futures Centre Spotted 1933 signals

Have you spotted a signal of change?

Register to receive the latest from the Futures Centre.
Sign up

  • 0
  • Share

Related signals

Our use of cookies

We use necessary cookies to make our site work. We'd also like to set optional analytics cookies to help us improve it. We won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences.

For more detailed information about the cookies we use, see our Cookies page.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We'd like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our 'Cookies page'.

>